Integramed America, Inc. (INMD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $14.91 +0.47%
Revenue Growth %: -1.7%
Financial Fact:
Income before income taxes: 2.17M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.7%
Financial Fact:
Income before income taxes: 2.17M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q2 adjusted EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.05 million versus the consensus estimate of $68.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
